RNA:RNA binding protein complexes in neurons and SIV encephalitis

RNA：神经元和 SIV 脑炎中的 RNA 结合蛋白复合物

• 批准号: 8937093
• 负责人: Kelly L Jordan-Sciutto
• 金额: $ 23.31万
• 依托单位: UNIVERSITY OF PENNSYLVANIA
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-04-01 至 2017-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8937093
• 关键词: AIDS Dementia Complex; Acquired Immunodeficiency Syndrome; Affect; Age; Animals; Anti-Retroviral Agents; Ataxia; Atrophic; Axon; Binding; Binding Sites; Bioinformatics; Cell Cycle Regulation; Cellular Structures; Chronic; Cognitive; Communication; Control Animal; Defect; Dendrites; Development; Disease; Distal; Encephalitis; Excitatory Neurotoxins; Fragile X Syndrome; Frontotemporal Dementia; Future; Gene Expression; Gene Proteins; Global Change; HIV; HIV encephalitis; HIV-associated neurocognitive disorder; Hereditary Disease; Impaired cognition; In Vitro; Infiltration; Inflammation; Link; Macaca; Maintenance; Mediating; Messenger RNA; Modeling; Natural Immunity; Nervous System Physiology; Nervous system structure; Neurons; Neurotoxins; Parkinson Disease; Pathologic; Patients; Polyribosomes; Primates; Process; Progressive Disease; Protein Binding; Protein Footprinting; Proteins; Proteomics; RNA; RNA Sequences; RNA Splicing; RNA Stability; RNA-Binding Proteins; Rattus; Reactive Oxygen Species; Regulation; Research Personnel; Ribonucleases; SIV; SIV encephalitis; Site; Synapses; Synaptic plasticity; Therapeutic; Tissues; Translations; Viral; antiretroviral therapy; cytokine; deep sequencing; experience; high risk; in vitro Model; in vivo Model; insight; interest; macrophage; metabolomics; myelination; nervous system disorder; neuroinflammation; neuron loss; neurotoxicity; nonhuman primate; novel; prevent; protein complex; public health relevance; research study; response; synaptogenesis; therapeutic target; transcriptome sequencing; transcriptomics

 DESCRIPTION (provided by applicant): HIV-Associated Neurocognitive Disorders (HAND) continue to affect ~50% of HIV(+) patients1-4, despite suppression of HIV replication with antiretroviral compounds1-4. With antiretroviral therapy, HAND is now a chronic, progressing disease leading to a spectrum of neurologic disorders. In more severe forms of disease, such as HIV-Associated Dementia (HAD), there is neuronal loss, but in milder forms of disease, synaptic damage is the more salient pathologic change8-14. Both neuronal loss and synaptic simplification are associated with macrophage infiltration and neuroinflammation 15-18, which are believed to be mediated by release of excitotoxins, reactive oxygen species (ROS), cytokines and viral proteins10,15,19-42. Transcriptomic, Proteomic, and Metabolomic approaches have identified several classes of genes and proteins that are dysregulated in HAND, including those regulating innate immunity, inflammasome formation, cell cycle regulation, myelination and synaptic development and function43-51. As synaptic damage correlates best with HAND progression, we are most interested in understanding these changes; however, the mechanisms underlying synaptodendritic damage remain elusive. A particular hurdle to understanding the contribution of gene expression in neurons is the presence of polyribosome tracts in the distal axons and dendrites of neurons where translation is regulated locally to provide rapid changes in gene expression resulting in synaptic plasticity. Local translation, splicing, and stability of RNA as wll as delivery of RNA to these sites require RNA binding proteins (RBPs). It is now clear that RNA regulation by RBPs contributes significantly to regulation of synapse formation, maintenance, and turnover as evidenced by the growing number of genetic disorders of the nervous system with defects in RBPs including Fragile X Syndrome, Frontotemporal Dementia, Spinocerabellar Ataxia, Spinomuscular Atrophy, and Parkinson disease53-55. In order to gain insight into the synaptic changes observed in neurons responding to HIV-associated neurotoxins in HAND, we propose to use a novel, high yield approach, protein interaction profile-sequencing (PIP-Seq), to identify global changes in RNA sequences bound by RBPs in neurons exposed to HIV-associated neurotoxins in an in vitro model of disease, and in the CNS of primates in an in vivo model of lentiviral encephalitis. PIP-Seq employs a novel RNase-mediated protein footprinting strategy in which all unbound RNA is digested by RNAses and RNA sequences protected by RBPs are subjected to deep sequencing. Combining information gained from PIP-seq with bioinformatics approaches, this high risk, high yield approach will provide insights into: the RBP-bound RNA sequences in neurons at baseline, the changes in RBP-bound RNA sequences in neurons responding to HIV-associated neurotoxins, the region of RNA molecules bound by RBP, the conservation of the bound sites across vertebrate species, the overrepresented biologic processes in which differentially RBP-bound RNAs function, the ability to distinguish putative SNPs linked to changes in RBP activity, and the means to identify known and novel RBPs that regulate RNAs linked to HIV-associated changes. Finally, identified RBP-bound RNA sequences will be compared with previous transcriptomic and proteomic results to gain insight into the mechanisms underlying changes in observed gene expression in HAND. This novel, high risk, high yield approach stands to provide valuable insight into changes in neuronal responses in HAND and in diseases beyond, and will provide the underpinnings for studies to increase both our understanding of basic neuronal function and how disease processes impact that function.

 描述(由申请人提供)：艾滋病毒相关神经认知障碍(HAND)继续影响约50%的艾滋病毒(+)患者1-4，尽管抗逆转录病毒化合物1-4抑制了艾滋病毒的复制。通过抗逆转录病毒治疗，手部现在是一种慢性、进展性疾病，会导致一系列神经疾病。在更严重的疾病形式中，如艾滋病毒相关性痴呆(HAD)，会有神经元丢失，但在较轻的疾病形式中，突触损伤是更显著的病理变化8-14。神经元丢失和突触简化都与巨噬细胞浸润和神经炎症15-18有关，这些炎症被认为是由兴奋性毒素、活性氧物种(ROS)、细胞因子和病毒蛋白10、15、19-42的释放所介导的。转录学、蛋白质组学和代谢组学的方法已经鉴定出几类基因和蛋白质在手中处于失调状态，包括调节先天性免疫、炎症体形成、细胞周期调节、髓鞘形成和突触发育以及功能43-51。由于突触损伤与手的进展最相关，我们最感兴趣的是了解这些变化；然而，突触树突损伤的机制仍然难以捉摸。理解神经元中基因表达的贡献的一个特殊障碍是神经元远端轴突和树突中存在多聚核糖体，其中翻译受到局部调控，以提供基因表达的快速变化，从而导致突触可塑性。RNA的局部翻译、剪接和稳定性以及将RNA运送到这些位点都需要RNA结合蛋白(RBPs)。现在很清楚，限制性商业惯例的RNA调节对突触的形成、维持和周转的调节有重要作用，限制性商业惯例中缺陷的神经系统遗传疾病的数量不断增加就证明了这一点，包括脆性X综合征、额颞部痴呆、脊梁骨性共济失调、脊髓瘤肌萎缩和帕金森病53-55。为了深入了解HIV相关神经毒素对手部HIV相关神经毒素反应的神经元中观察到的突触变化，我们建议使用一种新的、高效的方法，蛋白质相互作用谱-测序(PIP-Seq)，在体外疾病模型中识别暴露于HIV相关神经毒素的神经元中RBPs结合的RNA序列的全局变化，在体内慢病毒脑炎模型中识别灵长类动物中枢神经系统中RBPs结合的RNA序列的整体变化。PIP-Seq采用了一种新的RNase介导的蛋白质足迹策略，即所有未结合的RNA都被RNase消化，受限制性商业惯例保护的RNA序列进行深度测序。将从PIP-SEQ获得的信息与生物信息学方法相结合，这种高风险、高产量的方法将提供以下方面的见解：神经元中RBP结合的RNA序列在基线水平上的变化；神经元中响应艾滋病毒相关神经毒素的RBP结合RNA序列的变化；RBP结合的RNA分子的区域；脊椎动物物种中结合位点的保护；RBP结合RNA的不同功能的过度表达的生物过程；区分与RBP活性变化相关的假定SNP的能力；以及确定调节与HIV相关变化相关的RNAs的已知和新型限制性商业惯例的手段。最后，识别的RBP结合的RNA序列将与先前的转录和蛋白质组学结果进行比较，以深入了解观察到的基因表达变化的潜在机制。这种新颖、高风险、高收益的方法将为手部和疾病以外的神经元反应的变化提供有价值的见解，并将为研究增加我们对基本神经元功能的理解以及疾病过程如何影响该功能提供基础。